When U.S. Rep. Thomas Kean (R-NJ) returns to Congress after the end of summer recess on Sept. 12, one of the first bills he could consider is the “Support and Value Expectant (SAVE) Moms and Babies Act of 2023” (HR 427), which would restrict the availability of mail-order pills used in chemical abortions.